drugset
drugset / Trial / NCT02454387

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers

NCT02454387 ↗

Phase 1 Completed 141 enrolled Ono Pharmaceutical Co., Ltd.
RandomizedCrossoverDouble-blindTreatment

Summary

A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in healthy volunteers.

Timeline

Start
2015-05
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject ONO-4474 Unknown — —

Indications

osteoarthritis